◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocksAMAT › Revenue

Applied Materials Inc (AMAT) Revenue 2006–TTM

DATA UPDATED 2026-07-10

Applied Materials Inc annual revenue for fiscal TTM was $29.0 billion, an increase of 2.3% from $28.4 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.

AMAT Annual Revenue

Revenue (annual)TTM → 2026-04-302025-10-312024-10-312023-10-312022-10-312021-10-312020-10-312019-10-312018-10-312017-10-312016-10-312015-10-312014-10-312013-10-312012-10-312011-10-312010-10-312009-10-312008-10-312007-10-312006-10-31
Total Revenue$29.0B$28.4B$27.2B$26.5B$25.8B$23.1B$17.2B$14.6B$16.7B$14.7B$10.8B$9.7B$9.1B$7.5B$8.7B$10.5B$9.5B$5.0B$8.1B$9.7B$9.2B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

AMAT Quarterly Revenue

Revenue (quarterly)2026-04-302026-01-312025-10-312025-07-312025-04-302025-01-312024-10-312024-07-31
Total Revenue$7.9B$7.0B$6.8B$7.3B$7.1B$7.2B$7.0B$6.8B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

More AMAT metrics: Gross Profit · Operating Income · Net Income · EPS · EBITDA · Free Cash Flow · Shares Outstanding

All AMAT financial statements → Interactive AMAT charts →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.